Related Experiment Videos
Immune responses in hepatitis C virus infection
U Spengler1, M Lechmann, B Irrgang
1Department of General Medicine, University of Bonn, Germany.
Insights
Hepatitis C virus (HCV) infection often leads to chronic disease, but the host immune response is complex. Understanding viral and host interactions is key to developing better prevention and treatment strategies for HCV.
Area of Science:
- Immunology
- Virology
- Hepatology
Background:
- Hepatitis C virus (HCV) infection frequently results in persistent disease, potentially leading to cirrhosis and hepatocellular carcinoma.
- The precise pathogenesis of HCV infection remains incompletely understood, with both viral and host factors implicated in disease persistence.
Purpose of the Study:
- To review current knowledge on the host immune response to HCV.
- To explore the intricate interactions between the hepatitis C virus and the host immune system during infection.
Main Methods:
- Analysis of B lymphocyte expansion and antibody production in HCV-infected patients.
- Characterization of cytotoxic CD8+ T lymphocyte responses in peripheral blood and liver tissue.
- Investigation of T-B cell relationships and cytokine profiles in relation to HCV infection course.
Main Results:
- While antibodies against HCV proteins are common, natural infection typically fails to induce protective immunity, with reinfection possible.
- The immune system can exert partial control, as evidenced by the severe cholestatic course in immunocompromised patients.
- CD8+ T cell responses are polyclonal and multispecific, targeting various HCV proteins, while CD4+ T cell responses show an inverse correlation with antibody levels and a strong core protein response is linked to a benign infection course.
Conclusions:
- The host immune response to HCV is complex, involving both B and T cell immunity, with significant implications for disease progression.
- Understanding the interplay between viral factors, host immunity, and immunoregulation is crucial for developing effective prevention and treatment strategies against HCV.
- The unusual T-B cell dynamics and potential viral interference with immunoregulation highlight the need for further research into HCV pathogenesis.
Abstract:
Infection with the hepatitis C virus (HCV) commonly causes persistent disease, which may lead to cirrhosis and hepatocellular carcinoma. The pathogenesis of HCV infection is not well understood. It is most likely that both viral and host factors contribute to HCV persistence. This review focuses on the host's immune response to HCV in an attempt to present the current knowledge and concepts of the interactions between the virus and the host during HCV infection. Expansion of B lymphocytes and antibody production to virtually any HCV protein can be detected in most infected patients. However, observations in HCV-infected humans as well as experimental infections in chimpanzees suggest that natural HCV infection does not induce protective immunity, and reinfection can readily be demonstrated after inoculation with homologous or independent strains in HCV-seroconverted animals. Nevertheless, the immune system may gain partial control over HCV even in patients with chronic infection, as HCV infection in severely immunocompromised patients runs a particular cholestatic course which may rapidly lead to death from liver failure. Cytotoxic CD8+ T lymphocyte responses to HCV proteins have been characterized in peripheral blood and liver tissue and were found to be remarkably polyclonal and multispecific. Epitopes were identified on all of the putative HCV proteins, although only few major histocompatibility complex molecules were considered restriction elements. Immunoregulation may be particularly important in HCV infection. The HCV core and NS4 proteins appear to be most immunogenic for peripheral blood lymphocytes, and NS4 specific CD4+ lymphocytes are preferentially compartmentalized to the liver. However, there is an inverse relationship between CD4+ lymphocyte responses and antibody levels in infected patients. Furthermore, a strong cellular response to the HCV core protein apparently favors a benign course of infection. This unusual T-B cell relationship may be the consequence of an altered cytokine release during HCV infection. Alternatively, this virus may have found devices that can disturb immunoregulation in infected patients. A better understanding of these immunological mechanisms induced by HCV infection should make it possible to develop more effective strategies for the prevention and treatment of this insidious disease.